WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study

Clinical trial NCT01621724 · COMPLETED

Trial details

NCT number: NCT01621724
Sponsor: Cell Medica Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia Chronic Myeloid Leukaemia

Start date: 2012-04-01
Primary completion: 2018-05-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.